Medico Reach

MARCH 24, 2023

Even for cancers that are difficult to treat, new treatments and technologies improve patient survival rates. To address the shortcomings of existing treatments, routine utilization of patient data becomes crucial. billion by 2028. Nanotechnology By 2028, the Nanotechnology Medicines Delivery Market is expected to be $141.2

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Medico Reach

MARCH 24, 2023

Even for cancers that are difficult to treat, new treatments and technologies improve patient survival rates. To address the shortcomings of existing treatments, routine utilization of patient data becomes crucial. billion by 2028. Nanotechnology By 2028, the Nanotechnology Medicines Delivery Market is expected to be $141.2

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Pharmaceutical Technology

JUNE 16, 2023

In 2021, as part of the same Keynote-811 trial, the US Food and Drug Administration (FDA) granted accelerated approval to Keytruda for treating locally advanced unresectable or metastatic HER2-positive gastric or GEJ adenocarcinoma, in combination with trastuzumab and chemotherapy containing fluoropyrimidin and platinum.

Food and Drug Administration 52

Food and Drug Administration FDA Prospecting Food 52